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Spermatogenesis is a highly regulated process that involves both
mitotic and meiotic divisions, as well as cellular differentiation to
yield mature spermatozoa from undifferentiated germinal stem
cells. Although Gpat2 was originally annotated as encoding
a glycerol-3-phosphate acyltransferase by sequence homology
to Gpat1, GPAT2 is highly expressed in testis but not in
lipogenic tissues and is not up-regulated during adipocyte
differentiation. New data show that GPAT2 is required for
the synthesis of piRNAs (piwi-interacting RNAs), a group
of small RNAs that protect the germ cell genome from
retrotransposable elements. In order to understand the relationship
between GPAT2 and its role in the testis, we focused on Gpat2
expression during the first wave of mouse spermatogenesis.
Gpat2 expression was analysed by qPCR (quantitative real-time
PCR), in situ hybridization, immunohistochemistry and Western
blotting. Gpat2 mRNA content and protein expression were
maximal at 15 dpp (days post-partum) and were restricted to
pachytene spermatocytes. To achieve this transient expression,
both epigenetic mechanisms and trans-acting factors are involved.
In vitro assays showed that Gpat2 expression correlates with DNA
demethylation and histone acetylation and that it is up-regulated
by retinoic acid. Epigenetic regulation by DNA methylation
was confirmed in vivo in germ cells by bisulfite sequencing of
the Gpat2 promoter. Consistent with the initiation of meiosis
at 11 dpp, methylation decreased dramatically. Thus, Gpat2
is expressed at a specific stage of spermatogenesis, consistent
with piRNA synthesis and meiosis I prophase, and its on–
off expression pattern responds predominantly to epigenetic
modifications.
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INTRODUCTION
Spermatogenesis is a highly regulated process that involves both
mitotic and meiotic divisions, as well as cellular differentiation
to yield mature spermatozoa from undifferentiated germinal
stem cells. The endocrine regulation of spermatogenesis occurs
through the combined action of hormones and growth factors,
including the effects of retinoic acids (RAs), which are
vitamin A derivatives essential for meiosis initiation [1,2].
Epigenetic modifications and chromatin remodelling are also
important regulators in spermatogenesis [3]. PIWI-interacting
RNAs (piRNAs) are small non-coding RNAs synthesized in
germ cells, where they are believed to repress the expression of
deleterious retrotransposons, thereby ensuring genome integrity
during meiosis [4]. In mice these small non-coding RNAs interact
with the Argonaute family proteins (Ago and PIWI clades of
proteins), such as MIWI, MILI and MIWI2 members, which
also participate in piRNA biogenesis. Glycerol-3-phosphate
acyltransferase-2 (GPAT2) was unexpectedly found to be required
for piRNA biogenesis. The knockdown of Gpat2 in germline stem
cells impairs primary piRNA production, and it was shown that the
GPAT2 protein physically interacts with MILI in both germline
stem cells and mouse testis. The mechanism by which GPAT2
promotes piRNA production remains unknown, but because
this function occurs despite the absence of the acyltransferase
motif, H(X4)D, the regulation of piRNA production by
GPAT2 is unlikely to require acyltransferase enzymatic activity
[5].
GPAT isoforms catalyse the first and rate-limiting step in de
novo glycerolipid biosynthesis, acylating glycerol 3-phosphate
with a long-chain fatty acyl-CoA to form lysophosphatidic
acid (LPA). LPA is the substrate for 1-acylglycerol-3-phosphate
acyltransferase which catalyses the formation of phosphatidic
acid, the precursor for triacylglycerol and glycerophospholipid
biosynthesis. In mammals, four GPAT isoforms (GPAT1–GPAT4)
have been described which differ in their subcellular locations,
tissue expression pattern, substrate preference, transcriptional
regulation and sensitivity to sulfhydryl group reagents such as
N-ethylmaleimide [6]. GPAT1 and GPAT2 are mitochondrial
isoforms, whereas GPAT3 and GPAT4 are located in the
endoplasmic reticulum. GPAT1, GPAT3 and GPAT4 are highly
expressed in lipogenic tissues such as liver and adipose tissue
where they initiate the de novo synthesis of triacylglycerol
and glycerophospholipids [6]. During adipocyte differentiation
of 3T3-L1 fibroblasts, the expression of these three isoforms
increases; Gpat1 and Gpat4 are moderately induced (10- and 5-
fold, respectively) in differentiated adipocytes and Gpat3 is highly
induced (>60-fold) [7–9]. In contrast, Gpat2 mRNA expression
is not regulated by nutritional status, and it is at least 50-fold
higher in testis than in any other tissue [10].
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GPAT2 also differs from the other GPAT isoforms in that it
belongs to a group of genes named ‘cancer-testis genes’ (CTs).
CTs are important at specific stages during spermatogenesis,
but are expressed at low levels or not expressed at all in
somatic tissues. CTs are ectopically overexpressed in cancers
from different locations, and contribute to the tumour phenotype
[11,12]. We have shown that human GPAT2 is overexpressed in
several types of cancer and in cancer-derived human cell lines,
and that its expression contributes to the tumour phenotype,
because in tumour cells with diminished GPAT2 expression,
the proliferation and migration rates are lower, and in mouse
xenograft models, cells with diminished GPAT2 expression have
lower tumorigenicity [13].
To understand the physiological role of GPAT2 in the testis, we
focused on its developmental regulation during spermatogenesis.
Our data show that Gpat2 is expressed at a specific stage of the
spermatogenesis, consistent with meiosis I prophase and that its
on–off expression pattern responds predominantly to epigenetic
modifications and probably to RA signalling.
MATERIALS AND METHODS
Chemicals
All chemicals were purchased from Sigma unless otherwise
indicated.
Animals, cell lines and culture conditions
Animal protocols were approved by the Facultad de Ciencias
Me´dicas, Universidad Nacional de La Plata Institutional Animal
Care and Use Committee (Approval Number T10-02-2013). Male
BALB/c mice were housed on a 12-h light/12-h dark cycle with
free access to water and Cargill Rodent chow. Before testis
dissections, mice were killed in a CO2 chamber. Cells were
purchased from A.T.C.C. and were grown at 37 ◦C in a 5%
CO2 atmosphere with a 98% relative humidity. The hamster
cell line CHO (Chinese-hamster ovary)-K1 was maintained
in Ham’s F12 (Gibco) medium, the mouse macrophage cell
line RAW 264.7 and the embryonic fibroblast 3T3-L1 mouse
cell line in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco), the human breast cancer cell line derived from metastatic
pleural effusion MCF7 in RPMI 1640 medium (Gibco) and the
mouse Sertoli cell line TM4 in DMEM/Ham’s F12 (Gibco).
All media were supplemented with 10% FBS and antibiotics
(50 units/ml penicillin and 50 μg/ml streptomycin).
Analysis of mRNA transcription
Total RNA from BALB/c mouse testes at 3, 7, 11, 15, 20, 35
and 50 days post-partum (dpp), RAW 264.7 and 3T3L1 cells
was isolated with TRIzol Reagent (Invitrogen) according to the
manufacturer’s instructions. RNA quality was determined by
gel electrophoresis and 260/230 and 260/280 nm absorbance
ratios. A 1 μg sample of total RNA was used for cDNA
synthesis employing the High Capacity Reverse Transcription
Kit (Applied Biosystems). A 1/15 cDNA dilution was used for
the qPCR (quantitative real-time PCR) with ABsolute QPCR
SYBR Green Mix (Thermo). Primers were designed to amplify
a fragment of 187 bp between exon 16 (forward primer: 50-
ATCCTACTGCTGCTGCACCT-30) and exon 18 (reverse primer:
50-ACAGCAGCTTTGCACTCAGA-30) of the mouse Gpat2
transcript. The thermal profile was 95 ◦C for 15 min, followed
by 40 cycles of 95 ◦C for 30 s, 55 ◦C for 1 min and 72 ◦C
for 30 s, on a Stratagene Mx3000P apparatus. RNA expression
was quantified in duplicate using the 11CT method, and each
sample was normalized to two different housekeeping genes:
Gapdh (forward primer: 50-CTGGAGAAACCTGCCAAGTA-
30; reverse primer: 50-TGTTGCTGTAGCCCGTATTCA-30) and
Rpl13a (forward primer: 50-ATGACAAGAAAAAGCGGATG-
30; reverse primer: 50-CTTTTCTGCCTGTTTCCGTA-30) using
qBase software.
In silico evaluation of mouse Gpat2 expression
To validate experimental results regarding the Gpat2 mouse
expression profile during testis development, microarray data
from pre- and post-natal ages were collected to construct a
box plot graphic. Gene expression information was obtained
from GSE4818 (n = 21, mouse testis prenatal development)
and GSE12769 (n = 20, mouse testis postnatal development)
datasets, both developed in the Affymetrix genechip mouse
genome 430 2.0 platform (Mouse430_2). To generate a
homogeneous dataset in fetal and adult mouse testes, the
frozen robust multi-array analysis (fRMA) package from
Bioconductor (http://www.bioconductor.org/) was employed. The
fRMA preprocessing algorithm allows the analysis of independent
oligo-microarray studies/batches, and then combines the data for
further statistical analysis. Gpat2 mRNA expression level was
estimated by using the expression values of the Affymetrix probe
1456208_AT.
In situ hybridization
Riboprobes for in situ hybridization were prepared by digesting
mouse Gpat2 cDNA from the pcDNA3.1-Gpat2 construct at the
BamHI and EcoRI sites and subcloning the 1456 bp fragment
into pGEM11z(f) + vector (Promega). The tissue preparation,
probe synthesis and hybridization were performed at the
University of North Carolina at Chapel Hill Neuroscience Center
Molecular Neuroscience Core Facility (http://www.med.unc.
edu/neuroscience/core-facilities/molecular-neuroscience). Testes
from 7, 15 and 30 dpp mice were fixed in 4% paraformaldehyde
in 0.1 M PBS, and processed as previously described [14]. Slides
were visualized in an Olympus BX52 microscope.
Immunohistochemistry analysis
Testes from 7, 15, 30 and 40 dpp mice were fixed in Bouin’s
solution in the same paraffin block, and 4 μm sections were cut.
Samples were processed as previously described [14]. Slides were
counter-stained with haematoxylin to visualize the nuclei and
analysed with an Olympus BX52 microscope.
3T3-L1 differentiation assay
3T3-L1 cells were seeded in 12-well plates and grown in routine
medium until confluence, then stimulated with 2 μg/ml insulin,
0.25 μM dexamethasone and 0.5 mM isobutylmethylxanthine
(IBMX) [15]. Full differentiation was achieved on day 8. RNA
(triplicate samples) was isolated with TRIzol Reagent at different
times: 0, 12, 18, 24, 36, 48, 96, 144 and 192 h. A 1 μg sample
was used for cDNA synthesis, and Gpat2 content was evaluated
by qPCR.
Cloning of Gpat2 gene promoter regions
Primer pairs were used to amplify different regions of the putative
Gpat2 promoter upstream of the ATG start codon from mouse
genomic DNA; all included a terminal MluI (forward primer)
or HindIII (reverse primer) restriction sites. Forward primers:
− 1324P fragment ( − 1324/ + 2105) 50-ACGCGTGGTTCTG-
AAACTGGAGGTCAG-30, − 1165P fragment ( − 1165/ + 2105)
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50-ACGCGTGACCAGGAGAGGGTGCTAGA-3’, − 873P frag-
ment ( − 873/ + 2105) 50-ACGCGTACAGCTGACCAAAAGC-
CACT-30, − 642P fragment ( − 642/ + 2105) 50-ACGCGTTG-
GGGTAATTGGTTCTCACC-30, − 156P fragment ( − 156/
+ 2105) 50-ACGCGTTGTGGTACAGGCAGCAAGTC-30 and
+ 165P fragment ( + 165/ + 2015) 50-ACAGTCAGAGGCAAG-
CTGGT-30. The reverse primer was 50-AAGCTTTCTGTAAG-
ATCAGTGAATCAAGCAC-30. To test for possible downstream
regulation, the first non-translated exon of Gpat2 mRNA as well as
the first intron were included in the promoter constructs [16]. All
five fragments were amplified using iProof High-Fidelity DNA
Polymerase (Bio-Rad Laboratories), double digested with MluI
and HindIII and ligated into the pGL3-Basic Vector (Promega).
All plasmids were prepared using the Plasmid Miniprep kit
(Qiagen), quantified by UV spectrophotometry and sequenced.
Cell transfection, hormone response evaluation and luciferase
assay
To study basal promoter activity, CHO-K1 cells were seeded in
a 24-well plate. The next day Lipofectamine 2000 (Invitrogen)
was used to co-transfect 0.5 μg/well of each pGL3 construct
with 0.05 μg/well of pRL-Renilla Luciferase Reporter Vector
(Renilla). Thirty-six hours after transfection, cells were harvested
and lysed and luciferase activity was measured using the Dual-
Luciferase Reporter Assay System (Promega). Relative luciferase
activity was normalized by the Renilla luciferase activity. To
evaluate the hormone response, CHO-K1, MCF7 or TM4 cells
were seeded in a 48-well plate 24 h before Lipofectamine
2000 co-transfection with 1.14 μg/well of pGL3 constructs and
0.11 μg/well of Renilla luciferase plasmid. Five hours after
transfection, medium with hormones and lacking FBS, was added
to the cells. The next day, the medium was replaced with fresh
medium and hormones. Forty-eight hours after transfection, cells
were harvested and lysed and luciferase activity was measured as
described above. All experiments were performed in duplicate
and repeated at least twice. Hormones tested (concentration
range is indicated within parentheses): oestradiol (0.1–10 nM),
corticosterone (0.1–0.2 μM), all-trans-retinoic acid (ATRA) (2–
20 μM) and 9-cis-retinoic acid (9cisRA) (2–8 μM).
DAC and TSA treatments
The effect of the DNA methyltransferase inhibitor 5-aza-
2-deoxycitidine (DAC) and the histone deacetylase inhibitor
trichostatin A (TSA) on Gpat2 transcription was studied in
RAW 264.7 cells. Cells were seeded in a 12-well plate to reach
20% confluence. The next day, the medium was changed, and
cells were treated with 2 μM DAC (for ‘DAC’ and ‘TSA +
DAC’ treatments) or DMSO (control). Media and DAC were
replaced every 24 h for 3 days. TSA (500 nM) was added on
the fourth day (‘TSA’ and ‘TSA + DAC’ treatments) and cells
were harvested on day 5. Total RNA was isolated using TRIzol
Reagent (Invitrogen); 1 μg was used for cDNA synthesis and
Gpat2 mRNA content was measured by qPCR. Each treatment
was performed twice in triplicate.
In vitro methylation
The − 156P Gpat2 promoter construct (3 μg/reaction) was
incubated with 160 μM S-adenosylmethionine (SAM) and
10 units of SssI methylase (CpG methyltransferase, M.SssI,
New England Biolabs) (‘methylated’) or without enzyme
(‘unmethylated’) for 4 h at 37 ◦C, followed by a 20 min
inactivation at 60 ◦C. Plasmids were purified using the commercial
kit Illustra GFX PCR DNA and Gel Band Purification Kit (GE
Healthcare Life Sciences) and Lipofectamine 2000 (Invitrogen)
was used to co-transfect with Renilla luciferase plasmid
into CHO-K1 cells. The next day, cells were harvested and
luminescence was measured using the Dual-Luciferase Reporter
Assay System (Promega) and normalized to that of Renilla.
Germ cell purification
Germ cells were isolated from testes of mice at 11, 15 and 30
dpp as described in [17]. Cells were incubated overnight at 34 ◦C
in 4% CO2 to allow Sertoli cells to adhere to the culture plate
surface. The germ-cell-enriched supernatant was removed, and
centrifuged for 10 min at 800 g at room temperature, and then
genomic DNA was extracted from the pellet.
Bisulfite treatment and sequencing
Using DNeasy Blood & Tissue Kit (Qiagen), total DNA
was purified from whole testis from 7 dpp mice and from
germ cells isolated from mouse testis at selected ages. DNA
purity and concentration were evaluated using a NanoDrop
spectrophotometer (Thermo Scientific). For bisulfite treatment,
2 μg of genomic DNA was treated employing the EpiTect
Bisulfite Kit (Qiagen). PCR was performed using Taq DNA
polymerase (Invitrogen); the protocol was similar to a nested
PCR, but using the same set of primers. For each reaction, 100 ng
of bisulfite-converted DNA was used, and cycling conditions
were: 2 min at 94 ◦C for initial denaturation, followed by a
touchdown step of eight cycles of 45 s at 94 ◦C, 40 s at 64–
56 ◦C, 1.5 min at 72 ◦C; 30 cycles of 45 s at 94 ◦C, 40 s at
56 ◦C, 1.5 min at 72 ◦C and a final extension step of 6 min at
72 ◦C. Samples of 5 μl of these PCR products were then used as
templates with the same reaction conditions. Primers used were:
forward: 50-ATTGGTTGGTTTTTTAGTTGTTGAG-30; reverse:
50-ATTCCACATCAATCCCTACCTAAC-30. The products of
interest (197 bp) were gel purified with the Illustra GFX PCR
DNA and Gel Band Purification Kit, ligated into pGEMT-Easy
Vector (Promega) and transformed into Escherichia coli JM109
competent cells. Insertion was confirmed by restriction enzyme
digestion, and eight clones were chosen for sequencing.
Mouse testis subcellular fractionation and immunoblotting
Testes from 7, 15, 20 and 35 dpp BALB/c mice were removed,
rinsed with ice-cold PBS and submerged in precooled buffer
H [10 mM Hepes/KOH, pH 7.4, 0.25 M sucrose, 1 mM EDTA,
1 mM DTT, 0.002% protease inhibitor cocktail (general use) 1:6
(w/v)]. Testes were homogenized with ten up-and-down strokes in
a motor-driven Teflon-glass vessel. Large debris and nuclei were
pelleted by centrifuging twice at 600 g for 5 min. The supernatant
(post-nuclear homogenate) was centrifuged for 10 min at 10000 g.
The pellet was resuspended in 1 ml of buffer H/g of testis and
homogenized in a Dounce tissue grinder with a glass pestle to
obtain a mitochondria-enriched protein fraction.
Samples of 100 μg of the mitochondria-enriched protein
fractions were separated by SDS/PAGE (8 or 12% gel),
transferred to a PVDF membrane (Bio-Rad Laboratories) and
probed with a 1:500 dilution of anti-GPAT2 antibody [14]
or with 1:2000 of the anti-voltage-dependent anion channel
(VDAC) antibody (Affinity Bioreagents), as loading control.
Membranes were then washed extensively and probed with 1:5000
dilution of horseradish peroxidase-conjugated goat anti-rabbit
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IgG antibody (Thermo-Pierce). For chemiluminescent detection,
the membranes were incubated with Super Signal detection kit
(Thermo-Pierce).
RESULTS AND DISCUSSION
Gpat2 mRNA and protein are highly expressed in pachytene
spermatocytes
GPAT2 is expressed in male germ cells, particularly in primary
spermatocytes, and its expression changes during rat sexual
development [14]. The first round of spermatogenesis in mammals
is characterized by the synchronized appearance of particular
cell types at different stages of the spermatogenic cycle among
the seminiferous tubules, and this model was used to analyse
differential gene expression during spermatogenesis [18,19]. In
mouse testis, only Sertoli cells and spermatogonia populate the
seminiferous tubules until 10 dpp. Subsequently, meiotic cells
appear in the tubules: at 11 dpp meiosis advances no further than
the zygotene stage, at 13 dpp to the early pachytene, at 15 dpp
to the middle pachytene, at 18 dpp to the late pachytene, at 20
dpp to the round spermatid stage and at 30 dpp spermatids have
already reached the elongation phase and sperm tail accessory
structures are being constructed. After this period, synchrony is
lost and all stages of spermatogenesis can be observed; however,
apart from mature spermatozoa, pachytene spermatocytes and
round spermatids remain the most abundant germ cell types in
seminiferous tubules [20]. In order to study the relative expression
of Gpat2 mRNA during the first wave of spermatogenesis, total
RNA was extracted from testis at selected ages and expression
was assessed by qPCR (Figure 1A). The mRNA content was low
at 3 and 7 dpp, and then increased, reaching a peak at 15 dpp, after
which expression fell by 50% to a value that remained unchanged
throughout adulthood. To evaluate mRNA expression in the
seminiferous tubules, in situ mRNA hybridization was performed
on slides of mouse testis at 7, 15 and 30 dpp (Figure 1C). The
label was undetectable at 7 dpp, but positive staining was observed
at 15 and 30 dpp. Strong labelling was observed at 15 dpp and
most cells populating the tubules were positive for Gpat2 mRNA,
except for the basal germ cells corresponding to spermatogonia.
In contrast, at 30 dpp the label was detected only in primary
spermatocytes, and mRNA expression was abruptly extinguished
in the subsequent stages of spermatogenesis. These results are
consistent with the analysis of microarray data collected from
mouse testis, from fetal age to adulthood (duplicates in 11, 12,
14, 16 and 18 days post-coitum (dpc), 0, 3, 6, 8, 10, 14, 18, 20, 30
and 35 dpp) which shows the time course of gene expression
in murine testis development (GEO Datasets: GDS2098 and
GSE12769). Postnatal Gpat2 followed a similar profile to the one
described in the present study (Figure 1B), and the microarray data
demonstrated that Gpat2 transcription is transiently active during
embryonic development, reaching a peak at 15 dpc (Figure 1B).
To verify GPAT2 protein expression, Western blot analysis
and immunohistochemistry (IHC) were performed. Western
blotting showed that the protein expression peaked at day 20,
consistent with the high transcriptional rate at 15 dpp and
the moderate transcription level at 20 dpp (Figure 2A). IHC
was also performed on mouse testes at 7, 15, 30 and 40 dpp
(Figure 2B). Similar to the mRNA expression pattern, GPAT2
protein was undetectable in 7 dpp testis, whereas a positive
cytoplasmic signal was detected in testes from 15, 30 and 40
dpp mice. Again, the distribution of the signal varied among
the different germ cells within the seminiferous tubules. Strong
staining was present in nearly all spermatocytes at 15 dpp (when
pachytene spermatocytes predominate). This stain was localized
to pachytene spermatocytes at 30 and 40 dpp and became more
diffuse in later stages of spermatogenesis (Figure 2B). Thus,
Gpat2 mRNA expression and maximum GPAT2 protein content
within adult testis were restricted to pachytene spermatocytes.
This temporospatial profile suggests that GPAT2 plays a specific
role in spermatogenesis and that strict transcriptional regulatory
mechanisms operate to ensure an on–off expression pattern.
The specific role for GPAT2 in spermatogenesis is suggested
by its involvement in the metabolism of a class of small non-
coding RNAs called piRNAs that are predominantly synthesized
in germ cells; Gpat2 silencing in germline stem cells severely
impaired primary piRNA production. In addition, in both germline
stem cells and testis, GPAT2 interacts with MILI protein, a key
player in piRNA metabolism [5]. The expression of piRNAs
in mouse testis occurs at two distinct phases: pre-pachytene
piRNAs are present in fetal mice, are enriched in transposon
sequences, and are synthesized by the primary and secondary
(‘ping-pong’) pathways, whereas pachytene piRNAs originate
from discrete genomic loci (piRNA clusters), and their synthesis
is independent of the ping-pong cycle [21,22]. This expression
profile of Gpat2 reinforces the idea that GPAT2 functions in
the primary piRNA biosynthesis pathway, since Gpat2 expression
peaks not only when both pre-pachytene (embryonic) and
pachytene piRNA are synthesized, but also occurs simultaneously
with Mili transcription (GEO Datasets: GDS2098 and
GSE12769).
Evaluation of Gpat2 minimal promoter
Epigenetic modifications operate with trans-acting factors to
achieve transient gene expression and ensure the progression of
spermatogenesis. To identify the promoter region and study the
regulatory elements of the Gpat2 gene, the 50 sequence flanking
the transcription start site (TSS) (−1320 to translation start
site) was analysed by online programs and applications, such as
GPMiner, Alibaba 2.0, MethPrimer and Epigenomics (NCBI) to
recognize promoter elements such as the TATA box, CCAAT box
and GpC islands. The first intron was included because in other
genes, transcription factor-binding sites or CpG islands are present
in this region [16,23]. The Gpat2 promoter lacked a canonical
TATA box and/or CAAT boxes in the 50-flanking region, but a CpG
island containing ten CpG pairs was detected from − 92 to + 32.
These features are characteristic of a ‘CpG island promoter’ class
[24]. To establish the region of minimal promoter activity, serial
deletions of the putative promoter region were made, cloned into a
luciferase reporter vector and transiently transfected into CHO-K1
cells. Basal transcription promoter activity was located between
−156 and +1 position (Figure 3), a sequence that contains three
potential binding sites for Sp1 (specificity protein 1, which can
initiate transcription when the TATA box is absent [24]) and
the CpG island described above. These constructs were used to
evaluate the influence of CpG methylation or hormones on Gpat2
promoter activity.
Methylation status of Gpat2 promoter changes during the first wave
of spermatogenesis
qPCR and in situ hybridization experiments during the first
wave of spermatogenesis demonstrated that Gpat2 mRNA
transcription occurred transiently in meiotic cells; expression
was higher in pachytene spermatocytes and abruptly decreased in
subsequent stages of spermatogenesis. We previously speculated
that ectopic GPAT2 expression in human cancer cells could be
the consequence of epigenetic modifications [13]. Thus, because
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Figure 1 Gpat2 mRNA expression analysis during the first wave of spermatogenesis
(A) Gpat2 mRNA content was analysed in mouse testis at selected ages and the Gpat2 mRNA relative expression level for each sample was normalized to both Gapdh and Rpl13A mRNA expression
level. (B) In silico analysis of pre- and post-natal Gpat2 expression was performed using microarray information obtained from the public database GEO Profiles (NCBI). (C) mRNA expression was
assayed by in situ hybridization performed on slides of 7, 15 and 30 dpp mouse testis. Arrows indicate positive reaction. Scale bar = 50 μm.
epigenetic events are critical in regulating spermatogenesis,
we asked whether these mechanisms could regulate Gpat2
transcription during mouse spermatogenesis. To answer this
question, we first assayed the effect of chromatin modification
reagents such as the DNA methyltransferase inhibitor DAC and
the histone deacetylase inhibitor TSA on Gpat2 transcription. The
murine cell line RAW 264.7 expresses low basal levels of Gpat2,
but DAC treatment induced Gpat2 expression 2-fold (P < 0.01),
whereas TSA treatment did not change mRNA expression. The
combination of both TSA and DAC treatments enhanced Gpat2
transcription almost 6-fold (Figure 4A), illustrating synergistic
effects on Gpat2 transcription. These experiments demonstrate
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Figure 2 GPAT2 protein expression analysis during the first wave of spermatogenesis
(A) GPAT2 protein content was analysed in testis mitochondrial fractions extracted at selected ages and normalized to the expression of the mitochondrial VDAC. Results are expressed as the means
for three independent experiments +− S.D. (B) IHC was assessed in 7, 15, 30 and 40 dpp mouse testis (×600 magnification). Arrowheads indicate the germ cells showing a strong signal at 30 and
40 dpp. Scale bar = 50 μm. Sg, spermatogonia; PS, pachytene spermatocytes; RS, round spermatids; ES, elongating spermatids. Scale bar = 50 μm.
that epigenetic changes such as hypomethylation, have a profound
effect on the rate of Gpat2 transcription and that the modifications
on histone acetylation become important when methylation is low.
This result is consistent with microarray data showing that mice
null for histone deacetylase 2 highly up-regulate Gpat2 expression
in the heart, a tissue in which Gpat2 is not constitutively expressed
(GEO profile GDS2624/1456208_at/Gpat2). To determine
whether methylation has the opposite effect on the Gpat2
promoter, i.e. methylation is associated with Gpat2 silencing,
the construct − 156P containing the minimal promoter of Gpat2
and the typical CpG island located between − 92 and + 32,
was methylated in vitro and luciferase activity was assayed
(Figure 4B). Unmethylated construct activity was 20-fold higher
than the internal Renilla luciferase control, whereas methylated
construct activity was lower than the internal control (10% of
the activity), suggesting that CpG methylation of the Gpat2
minimal promoter prevents transcription. In summary, whereas
DNA hypomethylation and histone acetylation are associated with
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Figure 3 Basal promoter activity of the murine Gpat2 gene
Serial deletions of the putative promoter region were made, cloned into luciferase vector and transiently transfected into CHO-K1 cells. Relative luciferase activity was normalized to the Renilla
luciferase internal control. Results are expressed as the means +− S.D. of replicates from two independent experiments.
high transcription rates, DNA methylation of the Gpat2 promoter
prevents transcription.
To elucidate the methylation status of the Gpat2 promoter
in vivo, total genomic DNA was purified from 7 dpp mouse
testis and from germ cells isolated from mice at 11, 15 and
30 dpp. At 7 dpp all clones were fully methylated, at 11
dpp a dramatic hypomethylation occurred in all the CpG pairs
within the island, and at 15 dpp all clones were remethylated
(Figure 4C). Interestingly, at 30 dpp (when primary and secondary
spermatocytes populate the tubules) the clones presented an on–
off pattern: the CpG islands were either totally unmethylated
(37.5% of the clones) or fully methylated (62.5% of the clones).
To corroborate that promoter methylation is the mechanism by
which Gpat2 expression is repressed in other tissues, genomic
DNA from liver was bisulfite-modified and the Gpat2 CpG island
was sequenced. As expected, this region was totally methylated
(results not shown). Thus, hypomethylation occurs at a specific
time that is consistent with the initiation of meiosis (11 dpp)
and precedes the maximum mRNA content detected at 15 dpp.
Taken together, our data demonstrate that hypomethylation of the
CpG island present in the Gpat2 proximal promoter increases
gene expression. A similar correlation between methylation
status of the proximal promoter and gene expression was
also observed for another member of the piRNA pathway, the
mouse Miwi gene [25], whose temporospatial expression from
midpachytene spermatocytes to round spermatids was associated
with hypomethylation of the CpG island proximal promoter.
Besides the spermatogenic cells, PIWI genes are overexpressed
in some cancer types and this ectopic expression correlates with
poorer clinical outcomes, suggesting that PIWI genes play a
functional role in cancer biology [26]. Epigenetic mechanisms
ensure the transient expression of the piRNA pathway genes at
specific stages of spermatogenesis and their aberrant expression
in somatic cancer cells [27]. Whether the expression of piRNAs
and PIWI proteins in cancer is a consequence or a cause of
malignancy remains unclear. However, it has been confirmed
that the expression of piRNA pathway genes is essential for
the progression of spermatogenesis, i.e. the disruption of Miwi2
and Mili genes cause a meiotic-progression defect, loss of germ
cells and sterility [28,29]. In our previous work, we confirmed
not only the presence of human GPAT2 in the cancer-derived
cell line MDA-MB-231, but also its epigenetic regulation and
relevance for the development of the tumour characteristics,
since the GPAT2 knockdown dramatically decreased cellular
proliferation, migration and in vivo tumorigenicity. In addition, on
the basis of in silico information, high GPAT2 expression occurs
in human breast cancer, melanoma, lung cancer and prostate
cancer [13].
Gpat2 gene transcription is up-regulated in vitro by retinoic acid
The varying expression of GPAT2 protein in mouse testis
motivated us to search for hormone-responsive elements in its
promoter region, particularly for those related to male sexual
development and function. The promoter region used for analysis
was the one selected for the − 1324P construct, and the online
program Alibaba 2.1 [30] was used to predict transcription factor-
binding sites. This program uses the TRANSFAC public database,
which contains an extensive compilation of published binding
site data for eukaryotic transcription factors, their experimentally
proven binding sites and regulated genes. For this region the
program predicted seven glucocorticoid-response elements, nine
retinoid-response elements [both retinoid X receptor (RXR) and
RA receptor (RAR)], three oestrogen-response elements and two
progesterone-response elements. We transfected the − 1324P
construct into cell lines that express the receptor for the hormone
that was being evaluated. We tested Gpat2 promoter activity with
oestradiol, corticosterone and ATRA/9cisRA in MCF7, CHO-K1
or TM4 cell lines, respectively. No response was observed with
oestradiol or corticosterone at the tested concentrations (results
not shown). However, positive regulation was observed with two
active vitamin A metabolites, 9cisRA and ATRA (Figures 5A and
5B). We observed that 8 μM 9cisRA and 10 μM ATRA duplicated
− 1324P activity (Figures 5A and 5B), but no synergistic effect
was observed when both retinoids were present (results not
shown). All the Gpat2 active promoter constructs were up-
regulated by both isomers of RA. Because both basal activity and
the RA response decreased downstream of the − 156P construct
and because RA–retinoid receptor complexes usually interact with
promoters near the transcription initiating site, it is possible that
the predicted binding site for RA at + 89 in the first intron might
c° 2015 Authors; published by Portland Press Limited
218 M.B. Garcia-Fabiani and others
Figure 4 Epigenetic mechanisms involved in Gpat2 transcription regulation
(A) The effect of the DNA methyltransferase inhibitor DAC and the histone deacetylase inhibitor TSA on Gpat2 transcription on the murine cell line RAW 264.7 was assessed by qPCR and Gpat2
mRNA relative expression level for each sample was normalized to its Gapdh and Rpl13A mRNA expression level. Bars with different letters indicate statistical difference (P < 0.01, one-way ANOVA
and Tukey’s test). (B) In vitro methylation of the Gpat2 minimal promoter construct ( − 156P) was performed and both methylated and unmethylated constructs were transfected into CHO-K1 cells.
Promoter activity was measured as luciferase activity relative to the internal control Renilla luciferase (** P < 0.01, Student’s t test). (C) Total DNA from 7 dpp testes or from isolated germ cells from
11, 15 and 30 dpp mouse testes was purified and bisulfite-modified, and the methylation status of the CpG island located on the proximal promoter region was analysed after PCR amplification and
sequencing. The top bar shows a schematic representation of the location of CG pairs along the fragment that was amplified: inverted triangles represent the CG pairs and the grey box represents
the first exon. Average methylation status of each position among all the sequenced clones is represented by circles: a black filled circle indicates that all cytosines were methylated at that position
among all the clones (100 % methylated) and an empty circle indicates that all the cytosines were unmethylated at that position among all the clones (0 % methylated). Partially black circles indicate
intermediate percentages of clones with a methylated cytosine at that position. The average methylation for each position is shown for 7, 11 and 15 dpp, considering all of the clones sequenced in
each case (five to ten clones). However, at 30 dpp 37 % of the clones were almost fully unmethylated (10 % or less methylated cytosines) and 63 % were fully methylated (70 % or more methylated
cytosines). Thus, at this age, the average methylation of each position is shown separately for the unmethylated clones (37 % of the clones) or the methylated ones (63 % of the clones) to emphasize
the coexistence of two populations of germ cells in terms of Gpat2 promoter methylation status at 30 dpp.
be involved in the Gpat2 promoter retinoid response (Figures 5C
and 5D).
Taking into account that RA synthesized endogenously
by premeiotic spermatocytes autonomously induces meiotic
initiation by controlling the RAR-dependent expression of Stra8
[31] and that Gpat2 expression correlates with the onset of
prophase I of meiosis [at 13.5 dpc in ovaries (GEO profile
GDS2223/1456208_at/Gpat2) and at 15 dpp in testes (Figure 1)] it
could be speculated that RA may up-regulate Gpat2 transcription
in vivo. Increasing evidence demonstrates that ATRA influences
the epigenetic environment regulating both DNA demethylation
and histone acethylation/deacethylation [32–34]. Thus, the up-
regulation of Gpat2 expression by RA might be a consequence of
promoter demethylation, histone deacetylation and/or canonical
trans-activation. Further experiments are required to validate this
hypothesis.
Gpat2 expression is not induced when 3T3-L1 fibroblasts are
differentiated to adipocytes
Although Gpat2 was initially cloned by its sequence homology
to Gpat1, an enzyme that promotes triacylglycerol biosynthesis
from endogenous and exogenous acyl-CoAs, primarily in
liver [6], the role of GPAT2 in lipid metabolism remains
controversial. We previously reported that LPA, the product of
the GPAT-catalysed reaction, could not be detected when GPAT2
was overexpressed [14]. Overexpression of murine Gpat2 in
CHO-K1 cells shows no increase in GPAT activity when glycerol
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Figure 5 Retinoic acid up-regulates Gpat2 promoter activity
The − 1324P construct was transfected into TM4 cells and the effect of retinoids on Gpat2 promoter activity was evaluated with 2, 4, 6 and 8 μM 9cisRA (A) and 2, 5, 10 and 20 μM ATRA (B).
Both isomers significantly increased promoter activity (one-way ANOVA and Tukey’s test), and 8 μM 9cisRA and 10 μM ATRA doubled it. (C and D) The effect of 9cisRA and ATRA on Gpat2 active
promoter constructs was tested: all were significantly up-regulated by both isomers of RA (Student’s t test). Results represent means +− S.D. of the replicates from two independent experiments. **
P < 0.01, * P < 0.05. Luciferase activity is expressed relative to that of Renilla internal control.
3-phosphate and palmitoyl-CoA, oleoyl-CoA or linoleoyl-CoA
are used as substrates; in contrast, a 2-fold increase in a
chloroform-soluble product is observed when arachidonoyl-
CoA is used as a substrate, although this increase is
due to phosphatidic acid with no accumulation of LPA
[14]. Moreover, Gpat2 overexpression increases acylglycerol-
3-phosphate acyltransferase activity when both oleoyl-CoA
and arachidonoyl-CoA are used as substrates [14]. These
results strongly suggest that GPAT2 may have an alternative
acyltransferase activity. Additionally, GPAT2 expression is low
in liver and adipose tissue, and fasting and refeeding do not
alter the expression of murine Gpat2 [10]. In order to determine
whether GPAT2 might play a role in lipogenesis, its expression
was assessed in differentiating 3T3-L1 mouse fibroblasts. No
Gpat2 mRNA induction was detected after cells differentiated
into adipocytes (Figure 6), whereas, as expected, cells contained
numerous large lipid droplets and a high content of TAG (results
not shown). This result is consistent with the fact that the Gpat2
promoter lacks binding sites for factors that regulate lipogenesis,
such as the ones belonging to sterol-regulatory-element-
binding protein 1 (SREBP1), cholesterol-regulatory-element-
binding protein (ChREBP) or the peroxisome-proliferator-
activated receptor (PPAR) family and suggests that the primary
function of GPAT2 may be unrelated to the synthesis of
triacylglycerol.
In conclusion, the expression of GPAT2 during spermatogenesis
is consistent with the requirement for piRNA action and
its transient expression is determined primarily by epigenetic
modifications and possibly by RA, a key regulator of meiosis
entry.
Figure 6 Gpat2 expression decreases during 3T3-L1 differentiation into
adipocytes
Gpat2 mRNA content was evaluated by qPCR during 3T3-L1 mouse fibroblasts differentiation
into adipocytes and the Gpat2 mRNA relative expression level for each sample was normalized
to its Gapdh and Rpl13A mRNA expression level. The black arrow indicates the day when the
differentiation cocktail was added. Gpat2 mRNA content decreased after cell differentiation.
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